Back to User profile » Dr Yizhen Fu
Papers published by Dr Yizhen Fu:
HAIC Combined with Lenvatinib and Pembrolizumab for Unresectable Hepatocellular Carcinoma: A Retrospective Study
Liang J, Yang Z, Yang Z, Li H, Hong J, Pan Y, Fu Y, Wang J, Zhou Z, Zhang Y, Chen M, Chen J, Hu D
Journal of Hepatocellular Carcinoma 2026, 13:600557
Published Date: 26 May 2026
Social Support, Quality of Life, and Financial Toxicity Among Patients with Hepatocellular Carcinoma
Liu S, Xie Y, Li T, Huang Y, Xu D, Cai L, Fu Y, Chen J, Zhang Y, Huang J, Hu Z
Journal of Hepatocellular Carcinoma 2025, 12:1711-1723
Published Date: 5 August 2025
The Efficacy and Safety of Bevacizumab Plus Anti-PD-1/PD-L1 Inhibitors in Combination with Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma
Tang X, Chen J, Peng W, Yang Z, Hu L, Ye Z, Fu Y, Hu D, Zhou Z, Chen M, Zhang Y, Wang JC
ImmunoTargets and Therapy 2024, 13:559-569
Published Date: 26 October 2024
Laparoscopic Hepatectomy versus Open Hepatectomy After Conversion Therapy Using Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy for Patients with Initially Unresectable Hepatocellular Carcinoma
Yang Z, Hu Z, Fu Y, Hu D, Zhou Z, Chen M, Pan Y, Zhang Y
Journal of Hepatocellular Carcinoma 2023, 10:1157-1167
Published Date: 21 July 2023
Development and Validation of Prognostic Nomograms for Hepatocellular Carcinoma After Hepatectomy Based on Inflammatory Markers
Hu Z, Yuan Y, Hu Z, Liu Q, Fu Y, Hou J, Sun X, Li S, Duan W, Chen M
Journal of Hepatocellular Carcinoma 2022, 9:1403-1413
Published Date: 29 December 2022
Inflammation-Based Scores Predict Responses to PD-1 Inhibitor Treatment in Intrahepatic Cholangiocarcinoma
Yang Z, Zhang D, Zeng H, Fu Y, Hu Z, Pan Y, Chen J, Wang J, Zhang Y, Zhou Z, Xu L, Hu D, Chen M
Journal of Inflammation Research 2022, 15:5721-5731
Published Date: 6 October 2022
Antiviral Treatments Eliminate the Adverse Impacts of High Baseline HBV Loads on the Survival of HBV-Related HCC Patients
Hu Z, Sun X, Mei J, Hu Z, Yang Z, Hou J, Fu Y, Wang X, Chen M
Journal of Hepatocellular Carcinoma 2022, 9:315-325
Published Date: 19 April 2022
Prognostic Values of Alpha-Fetoprotein and Des-Gamma-Carboxyprothrombin in Hepatocellular Carcinoma in China: An Analysis of 4792 Patients
Pan YX, Sun XQ, Hu ZL, Xie W, Nie KX, Fang AP, Zhang YY, Fu YZ, Chen JB, Wang JC, Wang X, Zhang YJ, Hu DD, Chen MS
Journal of Hepatocellular Carcinoma 2021, 8:657-670
Published Date: 25 June 2021